We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
ADAR
  • premium

    TISSUE

  • premium

    CELL

  • PATHOLOGY

PATHOLOGY ATLAS

GENE/PROTEIN

Antibody validation

Dictionary

Level of antibody staining/expression





High
Medium
Low
Not detected

GENERAL INFORMATION

Gene name

ADAR

Gene description

Adenosine deaminase, RNA-specific

Protein class

Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins

Predicted localization

Intracellular

Number of transcripts

3
SHOW MORE

HUMAN PROTEIN ATLAS INFORMATION

RNA category

TCGA (cancer tissue):Expressed in all
HPA (cell line):Expressed in all
HPA (normal tissue):Expressed in all

Protein evidence

Evidence at protein level

Protein expression
normal tissue

Ubiquitous nuclear expression.

ANTIBODY IHC RELIABILITY

Data reliability
description

Antibody staining consistent with RNA expression data.

Reliability score

Supported based on 3 antibodies.
HPA003890 , HPA051519 , CAB056157
SHOW MORE

PROGNOSTIC SUMMARY

Prognostic marker in renal cancer (unfavourable).
Renal cancer p<0.001
Show all

RNA EXPRESSION OVERVIEW

TCGA dataset
RNA cancer category: Expressed in all

PROTEIN EXPRESSION

Colorectal cancer
Breast cancer
Prostate cancer
Lung cancer
Liver cancer

STAINING SUMMARY

HPA003890
HPA051519
CAB056157

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Most cancer tissues showed moderate nuclear immunoreactivity. Few testis, pancreas and urothelial cancers displayed strong staining. Several cases of prostate, renal, endometrial, cervical cancers and hepatocellular carcinomas were weakly stained or negative.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Most cancers exhibited moderate nuclear positivity. Most hepatocellular carcinomas were negative.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Cancer tissues displayed moderate to strong nuclear positivity.

GENE INFORMATION

Gene name

ADAR (HGNC Symbol)

Synonyms

ADAR1, G1P1, IFI4

Description

Adenosine deaminase, RNA-specific (HGNC Symbol)

Entrez gene summary

This gene encodes the enzyme responsible for RNA editing by site-specific deamination of adenosines. This enzyme destabilizes double-stranded RNA through conversion of adenosine to inosine. Mutations in this gene have been associated with dyschromatosis symmetrica hereditaria. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2010]

Chromosome

1

Cytoband

q21.3

Chromosome location (bp)

154582062 - 154627999

Protein evidence

Evidence at protein level (all genes)

Ensembl

ENSG00000160710 (version 83.38)

Entrez gene

103

UniProt

P55265 (UniProt - Evidence at protein level)

neXtProt

NX_P55265

Antibodypedia

ADAR antibodies

PROTEIN BROWSER

ADAR-001
ADAR-002
ADAR-007

PROTEIN INFORMATION

Splice variant

UniProt

Protein class

Gene ontology

Length & mass

Signal peptide
(predicted)

Transmembrane regions
(predicted)

ADAR-001
ENSP00000357459
ENST00000368474
P55265 [Direct mapping]
Double-stranded RNA-specific adenosine deaminase
Show all
Enzymes
   ENZYME proteins
   Hydrolases
   SPOCTOPUS predicted membrane proteins
Predicted intracellular proteins
Plasma proteins
Disease related genes
Potential drug targets
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0001649 [osteoblast differentiation]
GO:0001701 [in utero embryonic development]
GO:0002244 [hematopoietic progenitor cell differentiation]
GO:0002566 [somatic diversification of immune receptors via somatic mutation]
GO:0003677 [DNA binding]
GO:0003723 [RNA binding]
GO:0003726 [double-stranded RNA adenosine deaminase activity]
GO:0004000 [adenosine deaminase activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0006382 [adenosine to inosine editing]
GO:0006396 [RNA processing]
GO:0006397 [mRNA processing]
GO:0006606 [protein import into nucleus]
GO:0006611 [protein export from nucleus]
GO:0009615 [response to virus]
GO:0010467 [gene expression]
GO:0016020 [membrane]
GO:0016553 [base conversion or substitution editing]
GO:0016556 [mRNA modification]
GO:0019221 [cytokine-mediated signaling pathway]
GO:0030218 [erythrocyte differentiation]
GO:0031054 [pre-miRNA processing]
GO:0035196 [production of miRNAs involved in gene silencing by miRNA]
GO:0035280 [miRNA loading onto RISC involved in gene silencing by miRNA]
GO:0035455 [response to interferon-alpha]
GO:0043066 [negative regulation of apoptotic process]
GO:0044387 [negative regulation of protein kinase activity by regulation of protein phosphorylation]
GO:0044530 [supraspliceosomal complex]
GO:0044822 [poly(A) RNA binding]
GO:0045070 [positive regulation of viral genome replication]
GO:0045071 [negative regulation of viral genome replication]
GO:0045087 [innate immune response]
GO:0046872 [metal ion binding]
GO:0051607 [defense response to virus]
GO:0060216 [definitive hemopoiesis]
GO:0060337 [type I interferon signaling pathway]
GO:0060339 [negative regulation of type I interferon-mediated signaling pathway]
GO:0061484 [hematopoietic stem cell homeostasis]
GO:0098586 [cellular response to virus]
GO:1900369 [negative regulation of RNA interference]
Show all
1226 aa
136.1 kDa
No 0
ADAR-002
ENSP00000357456
ENST00000368471
P55265 [Direct mapping]
Double-stranded RNA-specific adenosine deaminase
Show all
Enzymes
   ENZYME proteins
   Hydrolases
   SPOCTOPUS predicted membrane proteins
Predicted intracellular proteins
Plasma proteins
Disease related genes
Potential drug targets
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003677 [DNA binding]
GO:0003723 [RNA binding]
GO:0003726 [double-stranded RNA adenosine deaminase activity]
GO:0004000 [adenosine deaminase activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005730 [nucleolus]
GO:0005737 [cytoplasm]
GO:0006382 [adenosine to inosine editing]
GO:0006396 [RNA processing]
GO:0006397 [mRNA processing]
GO:0006606 [protein import into nucleus]
GO:0006611 [protein export from nucleus]
GO:0009615 [response to virus]
GO:0010467 [gene expression]
GO:0016020 [membrane]
GO:0016553 [base conversion or substitution editing]
GO:0016556 [mRNA modification]
GO:0019221 [cytokine-mediated signaling pathway]
GO:0031054 [pre-miRNA processing]
GO:0035280 [miRNA loading onto RISC involved in gene silencing by miRNA]
GO:0035455 [response to interferon-alpha]
GO:0044387 [negative regulation of protein kinase activity by regulation of protein phosphorylation]
GO:0044530 [supraspliceosomal complex]
GO:0044822 [poly(A) RNA binding]
GO:0045070 [positive regulation of viral genome replication]
GO:0045087 [innate immune response]
GO:0046872 [metal ion binding]
GO:0060337 [type I interferon signaling pathway]
Show all
931 aa
103.6 kDa
No 0
ADAR-007
ENSP00000431794
ENST00000529168
H0YCK3 [Direct mapping]
Double-stranded RNA-specific adenosine deaminase
Show all
   SPOCTOPUS predicted membrane proteins
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0003723 [RNA binding]
GO:0003726 [double-stranded RNA adenosine deaminase activity]
GO:0004000 [adenosine deaminase activity]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005730 [nucleolus]
GO:0006396 [RNA processing]
Show all
1195 aa
132.6 kDa
No 0

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.